Combined Immune Checkpoint Blockade

Seminars in Oncology
Charles G Drake

Abstract

There are very few tumor types for which chemotherapy regimens are regularly curative; notable exceptions include testicular cancer and Hodgkin's lymphoma. In both cases combination chemotherapy approaches are required. Thus, it would seem only logical that combination immunotherapy approaches will be required to induce long-term remissions in the majority of cancer patients. Immune checkpoint blockade can be combined with several other interventions, including radiation therapy, chemotherapy and cancer vaccines. However, the observation that T cells that are rendered not-responsive or "exhausted" by recognition of tumor antigens express multiple non-overlapping checkpoint molecules suggests that immunotherapy approaches in which multiple checkpoint molecules are blocked may be particularly active in the clinic.

References

May 1, 1990·The Journal of Experimental Medicine·F TriebelT Hercend
May 1, 1996·International Immunology·T MiyazakiD Mathis
Dec 22, 1998·The Journal of Experimental Medicine·A J ZajacR Ahmed
Apr 3, 2003·European Journal of Immunology·Creg J Workman, Dario A A Vignali
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Nov 16, 2005·Nature Immunology·Chen ZhuVijay K Kuchroo
Oct 31, 2006·Biochemical and Biophysical Research Communications·Philipp S van de WeyerE Wolfgang Kuehn
Oct 13, 2007·The Journal of Clinical Investigation·Joseph F GrossoCharles G Drake
Feb 10, 2009·Cancer Immunology, Immunotherapy : CII·Jeffrey Weber
Sep 1, 2009·Journal of Autoimmunity·Gisa Tiegs, Ansgar W Lohse
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Junko MatsuzakiKunle Odunsi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Feb 9, 2011·The Journal of Experimental Medicine·Taku OkazakiTasuku Honjo
Feb 15, 2012·The Journal of Experimental Medicine·Drew Pardoll, Charles Drake
May 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas J LynchMartin Reck
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jul 23, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher J Nirschl, Charles G Drake

❮ Previous
Next ❯

Citations

Mar 13, 2016·Seminars in Oncology·Malgorzata E WojtowiczAsad Umar
Jul 19, 2016·Expert Opinion on Biological Therapy·Jiali YangWilliam C Cho
Feb 28, 2018·Journal of Hematology & Oncology·Xiaolei LiWeidong Han
Mar 17, 2016·Cancer Research·Michael J AllegrezzaJose R Conejo-Garcia
Sep 16, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sung Hugh ChoiKhalid Shah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.